These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 19167904)

  • 1. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
    Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
    Schachner T; Steger C; Heiss S; Bonaros N; Sterlacci W; Laufer G; Bonatti J
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):906-11. PubMed ID: 17923411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
    Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts.
    Schachner T; Oberhuber A; Zou Y; Tzankov A; Ott H; Laufer G; Bonatti J
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):302-6. PubMed ID: 15691686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts.
    Schachner T; Heiss S; Zipponi D; Tzankov A; Bernecker O; Kroell A; Laufer G; Bonatti J
    Heart Surg Forum; 2006; 9(1):E515-7. PubMed ID: 16401538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
    Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
    Wan S; Shukla N; Yim AP; Johnson JL; Angelini GD; Jeremy JY
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):494-500. PubMed ID: 17258588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts.
    Wan S; Arifi AA; Chan MC; Yip JH; Ng CS; Chow LT; Yim AP; Jeremy JY
    Eur J Cardiothorac Surg; 2006 May; 29(5):742-6; discussion 747. PubMed ID: 16581260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
    Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.
    Schachner T; Zou Y; Oberhuber A; Tzankov A; Mairinger T; Laufer G; Bonatti JO
    Ann Thorac Surg; 2004 May; 77(5):1580-5. PubMed ID: 15111146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
    Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
    Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
    J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
    Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
    Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts.
    Murphy GJ; Johnson TW; Chamberlain MH; Rizvi SI; Wyatt M; George SJ; Angelini GD; Karsch KR; Oberhoff M; Newby AC
    Cardiovasc Res; 2007 Feb; 73(3):607-17. PubMed ID: 17187765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.
    Rajathurai T; Rizvi SI; Lin H; Angelini GD; Newby AC; Murphy GJ
    Circ Cardiovasc Interv; 2010 Apr; 3(2):157-65. PubMed ID: 20332383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivenous support reduces early changes in human vein grafts: studies in whole blood perfused human vein segments.
    Stooker W; Niessen HW; Baidoshvili A; Wildevuur WR; Van Hinsbergh VW; Fritz J; Wildevuur CR; Eijsman L
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):290-7. PubMed ID: 11174734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of vein graft neointimal hyperplasia.
    Schachner T
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1065-72. PubMed ID: 16678591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an in vitro model of human saphenous vein hyperplasia.
    Castronuovo JJ; Smith TJ; Price RM
    J Vasc Surg; 2002 Jan; 35(1):152-7. PubMed ID: 11802147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.